Nurse Practitioner · Houston, TX
NPI
1053837716
Since 2017
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
163 services
Medicare patients, 2024
79
Average age 73
Drug cost, 2024
$2.1M
705 prescriptions
Company payments, 2025
$564
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ana C Adriazola was code 99215 (office e&m - established), 74 times for 41 patients. In total Ana C Adriazola billed 163 services in 6 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 74 | 41 | $89.08 | $6,592 |
| 99214 Office E&M - Established | Facility | 46 | 37 | $60.45 | $2,780 |
| 99213 Office E&M - Established | Facility | 20 | 19 | $42.47 | $849 |
By year: 2022 $17K for 246 services; 2023 $15K for 200 services; 2024 $11K for 163 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ana C Adriazola prescribed most often to Medicare patients was Levothyroxine Sodium, with 85 prescriptions and refills. In total Ana C Adriazola wrote 705 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 85 | 167 | 23 | $881 |
| Inlyta Axitinib | 41 | 41 | Under 11 | $841K |
| Ondansetron Odt Ondansetron | 38 | 38 | 16 | $573 |
| Pantoprazole Sodium Generic | 32 | 48 | Under 11 | $341 |
| Nifedipine Er Nifedipine | 31 | 47 | Under 11 | $390 |
| Tamsulosin Hcl Generic | 28 | 42 | Under 11 | $473 |
| Lisinopril Generic | 28 | 30 | Under 11 | $48.41 |
| Prednisone Generic | 27 | 33 | 12 | $129 |
| Gabapentin Generic | 26 | 28 | Under 11 | $169 |
| Lenvima Lenvatinib Mesylate | 25 | 25 | Under 11 | $584K |
| Losartan Potassium Generic | 25 | 55 | Under 11 | $188 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 19 | 19 | Under 11 | $252 |
| Cabometyx Cabozantinib S-Malate | 18 | 18 | Under 11 | $433K |
| Hydrochlorothiazide Generic | 17 | 25 | Under 11 | $11.83 |
| Hydrocortisone Generic | 17 | 17 | Under 11 | $102 |
Brand drugs: 189 claims; generic drugs: 516 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ana C Adriazola $564 ($564 in general payments such as food, travel and fees) from 7 companies. The largest payer was Exelixis Inc. with $315.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.